UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Carcinoembryonic antigen (CEA) as tumor marker in lung cancer

Lung cancer (Amsterdam, Netherlands), 2012-05, Vol.76 (2), p.138-143

2012

Volltextzugriff (PDF)

RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC

Lung cancer (Amsterdam, Netherlands), 2012-03, Vol.75 (3), p.306-312

2012

Volltextzugriff (PDF)

Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives

European respiratory review, 2011-03, Vol.20 (119), p.45-52

2011

Volltextzugriff (PDF)

1191PRETROSPECTIVE COMMUNITY BASED EXPLORATIVE STUDY ON CISPLATIN-BASED ADJUVANT CHEMOTHERAPY VS. SURGERY ONLY IN COMPLETELY RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv415-iv415

2014

Volltextzugriff (PDF)

Retrospective Community Based Explorative Study on Cisplatin-Based Adjuvant Chemotherapy Vs. Surgery Only in Completely Resected Stage Ib Non-Small Cell Lung Cancer (Nsclc)

Annals of oncology, 2014-09, Vol.25, p.iv415

2014

Volltextzugriff (PDF)

6IN SCLC CONSENSUS

Lung cancer (Amsterdam, Netherlands), 2011, Vol.71, p.S5-S5

2011

Volltextzugriff (PDF)

ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial

Annals of oncology, 2010-09, Vol.21 (9), p.1817-1824

2010

Volltextzugriff (PDF)

P.37 Very elderly NSCLC patients above 75 years: Response to chemotherapy and improvement in quality of life is achievable to the same extent as for younger patients during platinum-based doublet chemotherapy

Critical reviews in oncology/hematology, 2007-11, Vol.64, p.S48-S48

2007

Volltextzugriff (PDF)

MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer

Annals of oncology, 2009-10, Vol.20 (10), p.1660-1666

2009

Volltextzugriff (PDF)

36IN EUROPEAN TREATMENT GUIDELINES: SMALL CELL LUNG CANCER (SCLC)

Lung cancer (Amsterdam, Netherlands), 2009, Vol.64, p.S20-S20

Sørensen, J.B

2009

Volltextzugriff (PDF)

Predictive impact of RRM1 protein expression on vinorelbine efficacy in NSCLC patients randomly assigned in a chemotherapy phase III trial

Annals of oncology, 2013-02, Vol.24 (2), p.309-314

2013

Volltextzugriff (PDF)

191P - Prognostic and Predictive Impact Of KI-67 Index in Neo-Adjuvant Chemotherapy Before Surgery in Non-Small Cell Lung Cancer

Annals of oncology, 2012-09, Vol.23, p.ix80-ix80

2012

Volltextzugriff (PDF)

Prognostic and Predictive Impact Of KI-67 Index in Neo-Adjuvant Chemotherapy Before Surgery in Non-Small Cell Lung Cancer

Annals of oncology, 2012-09, Vol.23, p.ix80

2012

Volltextzugriff (PDF)

1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer

Annals of oncology, 2011-09, Vol.22 (9), p.1973-1980

2011

Volltextzugriff (PDF)

Munc18-1 phosphorylation by protein kinase C potentiates vesicle pool replenishment in bovine chromaffin cells

Neuroscience, 2006-12, Vol.143 (2), p.487-500

2006

Volltextzugriff (PDF)

Very Elderly Inoperable NSCLC Patients above 75 Years Compared to Younger Patients: Equal Activity of Platinum-Based Doublet Chemotherapy but Higher Toxicity

Annals of oncology, 2012-09, Vol.23, p.ix443

2012

Volltextzugriff (PDF)

Overall survival (OS) and forced vital capacity (FVC) results from the LUME-Meso study of nintedanib (N) + pemetrexed/cisplatin (PEM/CIS) vs placebo (P) + PEM/CIS in chemo-naïve patients (pts) with malignant pleural mesothelioma (MPM)

Annals of oncology, 2017-09, Vol.28, p.v569-v570

2017

Volltextzugriff (PDF)

Efficacité intracrânienne du sotorasib versus docétaxel dans le cancer bronchique non à petites cellules (CBNPC) métastatique muté KRAS G12C données utiles à la pratique issues d’un essai randomisé contrôlé

Revue des maladies respiratoires actualités, 2024-01, Vol.16 (1), p.265

2024

Volltextzugriff (PDF)

151P Mesothelioma tunica vaginalis testis: Characteristics and treatment outcome of a consecutive cohort

ESMO open, 2024-03, Vol.9, p.102546, Article 102546

2024

Volltextzugriff (PDF)

EP12.01-06 Metastatic NSCLC with G719X/S781I EGFR-mutations with acquired BRAF V600E mutation - response to Osimertinib, Dabrafenib and Trametinib

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S642

2023

Volltextzugriff (PDF)

OA03.06 Overall Survival and Forced Vital Capacity in the LUME-Meso Study of Nintedanib + Pemetrexed/Cisplatin in Patients with Mesothelioma: Topic: Medical Oncology

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1555-S1555

2017

Volltextzugriff (PDF)

OA03.06 Overall Survival and Forced Vital Capacity in the LUME-Meso Study of Nintedanib + Pemetrexed/Cisplatin in Patients with Mesothelioma

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1555

2017

Volltextzugriff (PDF)

Initiation and propagation of cleared channels in neutron-irradiated pure copper and a precipitation hardened CuCrZr alloy

Journal of nuclear materials, 2005-06, Vol.342 (1), p.164-178

2005

Volltextzugriff (PDF)

EP08.02-075 Maintained Complete Response for 8+ Years with Erlotinib Alone in Advanced Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S436

2022

Volltextzugriff (PDF)

EP08.02-044 Adding Alectinib Rescues Progression on Osimertinib Due to Acquired ALK p.R1275Q Variant in EGFR p.L858R-mutated NSCLC

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S417-S418

2022

Volltextzugriff (PDF)

1 – 25 von 203

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Englisch
(202)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Life Sciences & Biomedicine
(56)
Humans
(35)
Technology
(30)
Female
(26)
Biological And Medical Sciences
(21)
Male
(18)
Oncology
(17)
Adult
(16)
Exact Sciences And Technology
(16)
Medical Sciences
(16)
Physics
(16)
Engineering
(15)
Middle Aged
(15)
Physical Sciences
(15)
Materials Science
(13)
Animals
(11)
Aged
(10)
Engineering, Electrical & Electronic
(10)
Lung Neoplasms - Drug Therapy
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Carcinoembryonic antigen (CEA) as tumor marker in lung cancer

RT-PCR versus immunohistochemistry for correlation and quantification of ERCC1, BRCA1, TUBB3 and RRM1 in NSCLC

Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives

1191PRETROSPECTIVE COMMUNITY BASED EXPLORATIVE STUDY ON CISPLATIN-BASED ADJUVANT CHEMOTHERAPY VS. SURGERY ONLY IN COMPLETELY RESECTED STAGE IB NON-SMALL CELL LUNG CANCER (NSCLC)

Retrospective Community Based Explorative Study on Cisplatin-Based Adjuvant Chemotherapy Vs. Surgery Only in Completely Resected Stage Ib Non-Small Cell Lung Cancer (Nsclc)

6IN SCLC CONSENSUS

ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial

P.37 Very elderly NSCLC patients above 75 years: Response to chemotherapy and improvement in quality of life is achievable to the same extent as for younger patients during platinum-based doublet chemotherapy

MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer

36IN EUROPEAN TREATMENT GUIDELINES: SMALL CELL LUNG CANCER (SCLC)

Predictive impact of RRM1 protein expression on vinorelbine efficacy in NSCLC patients randomly assigned in a chemotherapy phase III trial

191P - Prognostic and Predictive Impact Of KI-67 Index in Neo-Adjuvant Chemotherapy Before Surgery in Non-Small Cell Lung Cancer

Prognostic and Predictive Impact Of KI-67 Index in Neo-Adjuvant Chemotherapy Before Surgery in Non-Small Cell Lung Cancer

1st ESMO Consensus Conference in lung cancer; Lugano 2010: Small-cell lung cancer

Munc18-1 phosphorylation by protein kinase C potentiates vesicle pool replenishment in bovine chromaffin cells

Very Elderly Inoperable NSCLC Patients above 75 Years Compared to Younger Patients: Equal Activity of Platinum-Based Doublet Chemotherapy but Higher Toxicity

Overall survival (OS) and forced vital capacity (FVC) results from the LUME-Meso study of nintedanib (N) + pemetrexed/cisplatin (PEM/CIS) vs placebo (P) + PEM/CIS in chemo-naïve patients (pts) with malignant pleural mesothelioma (MPM)

Efficacité intracrânienne du sotorasib versus docétaxel dans le cancer bronchique non à petites cellules (CBNPC) métastatique muté KRAS G12C données utiles à la pratique issues d’un essai randomisé contrôlé

151P Mesothelioma tunica vaginalis testis: Characteristics and treatment outcome of a consecutive cohort

EP12.01-06 Metastatic NSCLC with G719X/S781I EGFR-mutations with acquired BRAF V600E mutation - response to Osimertinib, Dabrafenib and Trametinib

OA03.06 Overall Survival and Forced Vital Capacity in the LUME-Meso Study of Nintedanib + Pemetrexed/Cisplatin in Patients with Mesothelioma: Topic: Medical Oncology

OA03.06 Overall Survival and Forced Vital Capacity in the LUME-Meso Study of Nintedanib + Pemetrexed/Cisplatin in Patients with Mesothelioma

Initiation and propagation of cleared channels in neutron-irradiated pure copper and a precipitation hardened CuCrZr alloy

EP08.02-075 Maintained Complete Response for 8+ Years with Erlotinib Alone in Advanced Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion

EP08.02-044 Adding Alectinib Rescues Progression on Osimertinib Due to Acquired ALK p.R1275Q Variant in EGFR p.L858R-mutated NSCLC

Suchergebnisse filtern